Contact Us Today|info@empharmd.com

Acute Decompensated Heart Failure

Warm and wet just sounds weird to me. Not only does it allow the mind to drift to undesirable places, it also isn’t reflective of real practice. Whenever I open a pharmacy based text or review article regarding acute decompensated heart failure (ADHF), the first section invariably begins to discuss the Forrester Classification.[1] While it’s a useful visual learning tool, the routine dropping of Swan-Ganz catheters is no more. And who knew Frank Starling is [...]

By |2019-01-02T10:30:49-05:00January 2nd, 2019|EM PharmD Core|0 Comments

Acute coronary syndromes

Sir William Osler said it best, that learning medicine without books is like going to sea without a map, but learning medicine without patients is like not going to sea at all. Learning any aspect of medicine without the proper context of a real patient, is just learning facts then having to figure out how they fit together later. Similarly, without proper framing of what your role is, a given subject can become overwhelming. Breaking [...]

By |2018-12-17T21:37:32-05:00December 17th, 2018|EM PharmD Core|0 Comments

A Breath of Fresh Air: Nebulized TXA for Hemoptysis

An 80-year-old male arrived at the Emergency Department (ED) in a serious condition: he was coughing up blood. Although he coughed up about three tablespoons (50cc/hr), he was hemodynamically stable. A physician approached me with an unfamiliar question: “Could we give him nebulized TXA?” I looked at him for a moment, nonplussed. “What?!” I exclaimed, “Hold on—let me look it up and get back to you.” Questions flooded my mind: Is it effective? Is it [...]

By |2018-11-14T11:00:00-05:00November 14th, 2018|EM PharmD Blog|0 Comments

Nausea and Vomiting in the ED: There’s Something Fishy Going On

Nausea and vomiting is a common chief complaint in the ED, one I never really paid much attention to unless prompted (appropriate agent to use in pregnancy, which medication to use for a patient with a prolonged QTc, etc.) - at least, that was my practice before I began practicing in Miami. In one of the many unforgettable cases I have had in the ED, there was a young patient who presented with nausea and vomiting. [...]

By |2018-10-30T10:00:00-05:00October 30th, 2018|EM PharmD Blog|0 Comments

Fosfomycin: The Forgotten Treasure

We have all been there, a patient with so many complicating factors that it’s difficult to choose the least worst option to treat a urinary tract infection. For example: a patient with a CrCl ~22 ml/min, a prolonged QTc, sulfa allergy (described as immediate death), and amoxicillin allergy (also somehow described as immediate death) who absolutely refuses to try a cephalosporin. How is it this difficult to treat a simple urinary tract infection?!?!?! There is [...]

By |2018-08-27T11:11:00-05:00August 27th, 2018|EM PharmD Blog|0 Comments

BCPS Recertification: Follow Up

In two previous post, I outlined my impressions of High-Yield Med Reviews based on my experience going through the modules and webinar. While I still stand behind my evaluation of HYMR, my assessment was somewhat limited because it was all before the exam. Now that I have my scores, I feel I can give a more complete assessment of HYMR. In a nutshell: I passed, and highly recommend HYMR. In the final days before the exam, [...]

By |2018-07-25T14:41:00-05:00July 25th, 2018|EM PharmD Blog|0 Comments

Choosing NOACs in the ED

Patient Case:A 62-year-old female presents to the ED with left lower extremity pain and swelling and is diagnosed with a LLE deep vein thrombosis (DVT) on ultrasound. The patient’s past medical history is significant for hypertension and she takes amlodipine at home. Laboratory values, pulse oximetry, and vital signs are within normal limits. The ED physician approaches you about discharge anticoagulation options and asks for a recommendation. Which agent would you recommend for outpatient management [...]

By |2018-06-29T21:00:00-05:00June 29th, 2018|EM PharmD Blog|0 Comments

The plague that is vancomycin troughs

How important are vancomycin levels? Not very.... at least as a marker of efficacy. True, higher levels probably are associated with increased nephrotoxicity (above 15 mcg/mL) - Antimicrob Agents Chemother. 2013 ;57:734-44But the notion that troughs of 15-20 mcg/mL are the holy grail of therapeutic drug monitoring targets is simply not supported by data.What we know: vancomycin AUC/MIC in the mid 300 to 400s (let's just say > 400) or so range is likely the [...]

By |2018-05-29T16:30:00-05:00May 29th, 2018|EM PharmD Blog|0 Comments